43
Views
1
CrossRef citations to date
0
Altmetric
Corrigendum

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]

Page 1513 | Published online: 30 Jul 2015